{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:28:08Z","timestamp":1771075688486,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.7759\/cureus.17608","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T15:47:20Z","timestamp":1630424840000},"source":"Crossref","is-referenced-by-count":2,"title":["Continuous Effectiveness of Pneumococcal 13-Valent Conjugate Vaccine on Pediatric Pneumococcal Otomastoiditis: Results of 15 Years of Active\/Prospective Surveillance in a Mexican Hospital on the Mexico-US Border"],"prefix":"10.7759","author":[{"given":"Enrique","family":"Chacon-Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Z","family":"Lopatynsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis I","year":"2016","unstructured":"Galanis I, Lindstrand A, Darenberg J, et al.. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J. 2016, 47:1208-18. 10.1183\/13993003.01451-2015","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany","volume":"11","author":"van der Linden M","year":"2016","unstructured":"van der Linden M, Falkenhorst G, Perniciaro S, Fitzner C, Im\u00f6hl M. Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany. PLoS One. 2016, 11:e0161257. 10.1371\/journal.pone.0161257","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF03399443","article-title":"Controlling pneumococcal disease around the globe","volume":"3","year":"2014","unstructured":"Controlling pneumococcal disease around the globe. Pneumonia. 2014, 3.139-203. 10.1007\/BF03399443","journal-title":"Pneumonia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002845","article-title":"Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: a modelling study","volume":"16","author":"Choi YH","year":"2019","unstructured":"Choi YH, Andrews N, Miller E. Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: a modelling study. PLoS Med. 2019, 16:e1002845. 10.1371\/journal.pmed.1002845","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1067351","article-title":"Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong","volume":"12","author":"Wu DB","year":"2016","unstructured":"Wu DB, Roberts C, Lee VW, Hong LW, Tan KK, Mak V, Lee KK. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016, 12:403-16. 10.1080\/21645515.2015.1067351","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177342","article-title":"Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea","volume":"12","author":"Heo JY","year":"2017","unstructured":"Heo JY, Seo YB, Choi WS, et al.. Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea. PLoS One. 2017, 12:e0177342. 10.1371\/journal.pone.0177342","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183191","article-title":"Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study","volume":"12","author":"Dom\u00ednguez \u00c1","year":"2017","unstructured":"Dom\u00ednguez \u00c1, Ciruela P, Hern\u00e1ndez S, et al.. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study. PLoS One. 2017, 12:e0183191. 10.1371\/journal.pone.0183191","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-015-0032-1","article-title":"Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia","volume":"13","author":"Ord\u00f3\u00f1ez JE","year":"2015","unstructured":"Ord\u00f3\u00f1ez JE, Orozco JJ. Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia. Cost Eff Resour Alloc. 2015, 13:6. 10.1186\/s12962-015-0032-1","journal-title":"Cost Eff Resour Alloc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis","volume":"12","author":"Balsells E","year":"2017","unstructured":"Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One. 2017, 12:e0177113. 10.1371\/journal.pone.0177113","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26650","article-title":"Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013","volume":"10","author":"Martinelli D","year":"2014","unstructured":"Martinelli D, Pedalino B, Cappelli MG, et al.. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013. Hum Vaccin Immunother. 2014, 10:33-9. 10.4161\/hv.26650","journal-title":"Hum Vaccin Immunother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170316","article-title":"Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study","volume":"12","author":"Cilveti R","year":"2017","unstructured":"Cilveti R, Olmo M, P\u00e9rez-Jove J, et al.. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study. PLoS One. 2017, 12:e0170316. 10.1371\/journal.pone.0170316","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1004-z","article-title":"Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control","volume":"16","author":"Thorrington D","year":"2018","unstructured":"Thorrington D, Andrews N, Stowe J, Miller E, van Hoek AJ. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Med. 2018, 16:13. 10.1186\/s12916-018-1004-z","journal-title":"BMC Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix673","article-title":"Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines","volume":"65","author":"Lewnard JA","year":"2017","unstructured":"Lewnard JA, Givon-Lavi N, Weinberger DM, Lipsitch M, Dagan R. Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines. Clin Infect Dis. 2017, 65:1853-61. 10.1093\/cid\/cix673","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/312935","article-title":"Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials","volume":"2012","author":"Fletcher MA","year":"2012","unstructured":"Fletcher MA, Fritzell B. Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials. Int J Otolaryngol. 2012, 2012:312935. 10.1155\/2012\/312935","journal-title":"Int J Otolaryngol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-018-0511-z","article-title":"Acute mastoiditis in an Italian pediatric tertiary medical center: a 15-year retrospective study","volume":"44","author":"Balsamo C","year":"2018","unstructured":"Balsamo C, Biagi C, Mancini M, Corsini I, Bergamaschi R, Lanari M. Acute mastoiditis in an Italian pediatric tertiary medical center: a 15-year retrospective study. Ital J Pediatr. 2018, 44:71. 10.1186\/s13052-018-0511-z","journal-title":"Ital J Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.3924","article-title":"Trends in otitis media-related health care use in the United States, 2001-2011","volume":"168","author":"Marom T","year":"2014","unstructured":"Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr. 2014, 168:68-75. 10.1001\/jamapediatrics.2013.3924","journal-title":"JAMA Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00289-14","article-title":"Acute mastoiditis in the pneumococcal conjugate vaccine era","volume":"21","author":"Tamir SO","year":"2014","unstructured":"Tamir SO, Roth Y, Dalal I, Goldfarb A, Marom T. Acute mastoiditis in the pneumococcal conjugate vaccine era. Clin Vaccine Immunol. 2014, 21:1189-91. 10.1128\/CVI.00289-14","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26968","article-title":"Pediatric acute mastoiditis in the era of pneumococcal vaccination","volume":"128","author":"Tawfik KO","year":"2018","unstructured":"Tawfik KO, Ishman SL, Tabangin ME, Altaye M, Meinzen-Derr J, Choo DI. Pediatric acute mastoiditis in the era of pneumococcal vaccination. Laryngoscope. 2018, 128:1480-5. 10.1002\/lary.26968","journal-title":"Laryngoscope"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/2051013614547199","article-title":"Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital","volume":"2","author":"Chacon-Cruz E","year":"2014","unstructured":"Chacon-Cruz E, Rivas-Landeros RM, Volker-Soberanes ML. Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital. Ther Adv Vaccines. 2014, 2:155-8. 10.1177\/2051013614547199","journal-title":"Ther Adv Vaccines"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2049936119839312","article-title":"12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant Staphylococcus aureus","volume":"6","author":"Chacon-Cruz E","year":"2019","unstructured":"Chacon-Cruz E, Rivas-Landeros RM, Volker-Soberanes ML, Lopatynsky-Reyes EZ, Becka C, Alvelais-Palacios JA. 12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant Staphylococcus aureus. Ther Adv Infect Dis. 2019, 6:2049936119839312. 10.1177\/2049936119839312","journal-title":"Ther Adv Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/2051013616650158","article-title":"Neisseria meningitidis and Streptococcus pneumoniae as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance","volume":"4","author":"Chacon-Cruz E","year":"2016","unstructured":"Chacon-Cruz E, Martinez-Longoria CA, Llausas-Magana E, et al.. Neisseria meningitidis and Streptococcus pneumoniae as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance. Ther Adv Vaccines. 2016, 4:15-29. 10.1177\/2051013616650158","journal-title":"Ther Adv Vaccines"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.35248\/2576-389X.4.128","article-title":"Otomastoiditis: thirteen years of active surveillance in a Northern Mexican Hospital (Mexico-USA-border): pneumococcus as leading cause, and high impact of pneumococcal 13-valent conjugate vaccine","volume":"4","author":"Chacon-Cruz E","year":"2019","unstructured":"Chacon-Cruz E, Lopatynsky-Reyes EZ, Rivas-Landeros RM, Zapata-Cosain LA. Otomastoiditis: thirteen years of active surveillance in a Northern Mexican Hospital (Mexico-USA-border): pneumococcus as leading cause, and high impact of pneumococcal 13-valent conjugate vaccine. 2019, 4:1-4. 10.35248\/2576-389X.4.128"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/s1020-49892009000300011","article-title":"The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence","volume":"25","author":"Valenzuela MT","year":"2009","unstructured":"Valenzuela MT, O'Loughlin R, De La Hoz F, et al.. The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence. Rev Panam Salud Publica. 2009, 25:270-9. 10.1590\/s1020-49892009000300011","journal-title":"Rev Panam Salud Publica"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1334555","article-title":"Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?","volume":"16","author":"Avila-Aguero ML","year":"2017","unstructured":"Avila-Aguero ML, Ulloa-Gutierrez R, Falleiros-Arlant LH, Porras O. Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?. Expert Rev Vaccines. 2017, 16:1-4. 10.1080\/14760584.2017.1334555","journal-title":"Expert Rev Vaccines"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ067","article-title":"Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era","volume":"60","author":"Kaplan SL","year":"2015","unstructured":"Kaplan SL, Center KJ, Barson WJ, et al.. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015, 60:1339-45. 10.1093\/cid\/civ067","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67158-continuous-effectiveness-of-pneumococcal-13-valent-conjugate-vaccine-on-pediatric-pneumococcal-otomastoiditis-results-of-15-years-of-activeprospective-surveillance-in-a-mexican-hospital-on-the-mexico-us-border","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:12Z","timestamp":1707506952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67158-continuous-effectiveness-of-pneumococcal-13-valent-conjugate-vaccine-on-pediatric-pneumococcal-otomastoiditis-results-of-15-years-of-activeprospective-surveillance-in-a-mexican-hospital-on-the-mexico-us-border"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.17608","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}